A case of asymptomatic hyperCKemia for 40 years leading to a diagnosis of treatable immune-mediated necrotizing myopathy

Immune-mediated necrotizing myopathy (IMNM) is a rare but treatable inflammatory myopathy characterized by severe muscle necrosis with minimal inflammatory infiltration. IMNM typically presents with progressive proximal muscle weakness and markedly elevated serum creatine kinase (CK) levels. Here, we report a unique case of IMNM associated with anti-signal recognition particle (SRP) antibody, in which hyperCKemia persisted for 40 years before the onset of muscle symptoms. The extremely prolonged asymptomatic course initially suggested a hereditary myopathy; however, the absence of selective fatty replacement on muscle MRI pointed toward an inflammatory etiology. This imaging finding guided the diagnosis toward IMNM, a treatable condition, and led to successful immunotherapy with normalization of CK levels and marked improvement in muscle strength over 12 months.

Authors

Institutions

Publication Details

Journal
Neuromuscular Disorders
Published
2025-09-16
DOI
https://doi.org/10.1016/j.nmd.2025.106215
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A case of asymptomatic hyperCKemia for 40 years leading to a diagnosis of treatable immune-mediated necrotizing myopathy

Nobuyuki Eura, Takao Kiriyama, A. Yamanaka, Kazuma Sugie et al.
Neuromuscular Disorders
Inflammatory Myopathies and Dermatomyositis
article

A case of asymptomatic hyperCKemia for 40 years leading to a diagnosis of treatable immune-mediated necrotizing myopathy

Nobuyuki Eura, Takao Kiriyama, A. Yamanaka, Kazuma Sugie, Ichizo Nishino, Mayu Sugata, R. Ishida, Yukako Nishimori
article en

Abstract

Immune-mediated necrotizing myopathy (IMNM) is a rare but treatable inflammatory myopathy characterized by severe muscle necrosis with minimal inflammatory infiltration. IMNM typically presents with progressive proximal muscle weakness and markedly elevated serum creatine kinase (CK) levels. Here, we report a unique case of IMNM associated with anti-signal recognition particle (SRP) antibody, in which hyperCKemia persisted for 40 years before the onset of muscle symptoms. The extremely prolonged asymptomatic course initially suggested a hereditary myopathy; however, the absence of selective fatty replacement on muscle MRI pointed toward an inflammatory etiology. This imaging finding guided the diagnosis toward IMNM, a treatable condition, and led to successful immunotherapy with normalization of CK levels and marked improvement in muscle strength over 12 months.

Neuromuscular DisordersVol. 56-57
National Center of Neurology and Psychiatry (JP), Nara Medical University Hospital (JP), Nara Medical University (JP)
Openalex Percentile: Top 66%
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A case of asymptomatic hyperCKemia for 40 years leading to a diagnosis of treatable immune-mediated necrotizing myopathy — Nobuyuki Eura, Takao Kiriyama, et al. · Neuromuscular Disorders (2025) | TGRS Research Map | TGRS